Search research articles
Contact Us
Filters
Showing results (11-20 of 15) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 15 results.
Blood
|
December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells
Don M Benson, Jianhua Yu, Brian Becknell, et al.
Blood
|
May 4, 2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2008
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Ramiro Garzon, Michela Garofalo, Maria Paola Martelli, et al.
Cancer Cell
|
April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia
Shujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.
Blood
|
August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Joshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 15) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 15 results.
Blood
|
December 9, 2008
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells
Don M Benson, Jianhua Yu, Brian Becknell, et al.
Blood
|
May 4, 2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 2008
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Ramiro Garzon, Michela Garofalo, Maria Paola Martelli, et al.
Cancer Cell
|
April 14, 2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia
Shujun Liu, Lai-Chu Wu, Jiuxia Pang, et al.
Blood
|
August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Joshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Page
of 2